Blog

Insights on clinical trials & drug development

Analysis, trends and data stories from the Clival team, newest first.

Blog Image Featured Category: Clinical Trial 29 July 2026 7 min read

The Future of Drug Pipeline Analysis: What Pharma Leaders Need to Know

The rate of innovation is impressive both in terms of the opportunities it offers, and in terms of the complexity with which strategic decisions have to be made.

Read article
Blog Image Category: Clinical Trial 20 July 2026 6 min read

The Rise of Predictive Clinical Intelligence: What's Next for Pharma?

Discover how Predictive Clinical Intelligence, AI, and real-time analytics are transforming clinical drug research, drug development clinical trial phases, and the phases of drug development to help pharmaceutical companies make faster, smarter decisions.

Read article
Blog Image Category: Drug Development 8 July 2026 9 min read

What Global Drug Pipelines Reveal About the Future of Medicine

It's the structured path a molecule follows from lab to market: preclinical research, Phase I (safety), Phase II (efficacy and dosing), Phase III (large-scale confirmation), regulatory review, and Phase IV post-market monitoring. As of 2026, nearly half of the roughly 23,000 active global pipeline drugs are still in the preclinical stage alone.

Read article
Blog Image Category: Clinical Trial 3 July 2026 7 min read

The Future of Pharma Supply Chains

Discover how AI, real-time API intelligence, phases of pharmaceutical development, and API clinical trial data are transforming pharmaceutical supply chains through smarter forecasting, risk management, and strategic decision-making.

Read article
Blog Image Category: Clinical Trial 23 June 2026 7 min read

How to Prevent API Shortages Using Predictive Supplier Insights

Learn how predictive supplier insights help prevent API shortages by identifying risks early, improving sourcing decisions, and ensuring supply continuity.

Read article
Blog Image Category: Drug Development 17 June 2026 7 min read

The New Era of Rare Disease Drug Development: Trends to Watch

Here is a number that should stop you: more than 10,000 rare diseases have been identified globally, yet fewer than 500 have an approved treatment.

Read article
Blog Image Category: Clinical Trial 8 June 2026 6 min read

Why Every Pharma Company Needs a Unified Intelligence Platform in 2026

This is why more pharmaceutical companies are investing in unified intelligence platforms that centralize data, improve visibility, and support better decision-making across the drug development lifecycle.

Read article
Blog Image Category: Clinical Trial 2 June 2026 5 min read

How Early-Phase Pipeline Tracking Can Unlock High-Value Licensing Deals

Discover how early-phase pipeline tracking helps pharmaceutical companies identify high-value licensing opportunities, assess risks, and gain competitive advantage.

Read article
Blog Image Category: Drug Development 27 May 2026 5 min read

The Rise of First in Class Drugs: What the latest clinical data

Backed by latest FDA data, this article analyzes approval trends, clinical challenges, and innovation drivers in pharmaceutical R&D.

Read article
Blog Image Category: Clinical Trial 30 April 2026 5 min read

10 Best-Selling Cancer Drugs by Estimated Global Sales (2025-2026)

Oncology is printing money. There is no other therapy area in global pharma that even comes close to the numbers being put up by cancer drugs right now.

Read article

Page 2 of 9 · 84 articles

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!